AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
The reported earnings also exceeded the guidance of $2.18-$2.22. However, earnings declined 6.1% year over year. ABBV's revenues of $12.31 billion beat the Zacks Consensus Estimate of $11.99 billion. Sales rose 0.7% year over year on a reported basis and 1.6% on an operational basis. The upside can be attributed to a rise in product sales of key drugs like Rinvoq, Skyrizi, Venclexta and Vraylar, partially offset by declining sales of Humira and Imbruvica. All growth rates mentioned below are on a year-on-year basis and at constant exchange rates (CER). Quarter in Detail In immunology, AbbVie's flagship drug, Humira, recorded a year-over-year sales decline of 35.2% to $2.27 billion. Sales in the United States declined 39.9% to $1.77 billion, while ex-U.S. market sales were down 11.6% on an operating basis to $499 million. The drug's sales beatthe Zacks Consensus Estimate and our model estimates of $2.23 billion and $2.24 billion, respectively. This substantial decline in Humi
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Chemical Peel Market, 47% of Growth to Originate from North America, Technavio [Yahoo! Finance]Yahoo! Finance
- 3 Top Dividend Stocks to Maximize Your Retirement Income [Yahoo! Finance]Yahoo! Finance
- Pacific Software Inc. Announces a Landmark Asset Acquisition from Dreamaderm Inc. [Yahoo! Finance]Yahoo! Finance
- AbbVie to Present at the Bank of America Securities Healthcare ConferencePR Newswire
- Drug Delivery Technologies Market Report 2024-2034 - Sustainable and Eco-friendly Innovations in Drug Delivery Technologies [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 4/26/24 - Miss
ABBV
Sec Filings
- 5/3/24 - Form 10-Q
- 4/26/24 - Form 8-K
- 4/3/24 - Form 8-K
- ABBV's page on the SEC website